Stock Market News

Tourmaline shares edge lower despite phase 2 trial results

May 20, 2025 - 13:06
 0
Tourmaline shares edge lower despite phase 2 trial results
Read More

Tags:

Previous Article

Goldman Sachs downgrades Allianz to “neutral” after strong share price rally

Next Article

Canada CPI set to decline in April amid inflation risks from US tariffs

Related Posts

Airsupra shows significant improvement in asthma treatm...

May 19, 2025  0

European earnings show resilience amid market volatility: BlackRock

European earnings show resilience amid market volatilit...

May 13, 2025  0

Germany stocks higher at close of trade; DAX up 0.58%

Germany stocks higher at close of trade; DAX up 0.58%

May 19, 2025  0